
Daniel Shoskes MD, FRCS(C)
@dshoskes
Urologist /Lutenist. My views ≠ employer's. Music interpretations ≠ composer's intent. VP Med Director Uro-Oncology, Ferring Pharmaceuticals. Emeritus Prof CCF
ID: 22875186
http://www.dshoskes.com 05-03-2009 03:45:02
5,5K Tweet
1,1K Followers
371 Following



#GU25 Sia Daneshmand, M.D. presented the TiP: ABLE-22: A randomized, open-label, phase 2 study evaluating the safety and efficacy of nadofaragene firadenovec alone or + GEM/DOC or PEMBRO 🔹high-risk BCG-unresponsive NMIBC with CIS ± concomitant high-grade Ta/T1 pts 🔹Primary endpoint:





Mark Tyson, MD, (Mark Tyson) and Jacob Moyer highlight real-world data on nadofaragene firadenovec in BCG-unresponsive #NMIBC. | Mayo Clinic Urology #blcsm urologytimes.com/view/investiga…












